StockData
Travere Therapeutics, Inc. logo

Travere Therapeutics, Inc. (TVTX) stock

TVTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2027, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 6/30701% above fair value
$47.00−1.30 (-2.69%)

Close on Nov 20, 2026Market cap $4.43BP/E –Yield –

Travere Therapeutics pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Travere Therapeutics's pe ratio was 15.8× on Oct 31, 2016, against 248.4× a year earlier.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2016Oct 31, 201615.8×+0.7
2015Dec 31, 201515.2×–

More Travere Therapeutics figures

See a number that looks wrong?